- Home
- ZVRA vs DSU Comparison
ZVRA vs DSU Comparison
Compare ZVRA & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- DSU
- Stock Information
- Founded
- ZVRA 2006
- DSU 1998
- Country
- ZVRA United States
- DSU United States
- Employees
- ZVRA N/A
- DSU N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- DSU Finance Companies
- Sector
- ZVRA Health Care
- DSU Finance
- Exchange
- ZVRA Nasdaq
- DSU Nasdaq
- Market Cap
- ZVRA 458.5M
- DSU 510.1M
- IPO Year
- ZVRA 2015
- DSU N/A
- Fundamental
- Price
- ZVRA $8.15
- DSU $10.72
- Analyst Decision
- ZVRA Strong Buy
- DSU
- Analyst Count
- ZVRA 7
- DSU 0
- Target Price
- ZVRA $21.20
- DSU N/A
- AVG Volume (30 Days)
- ZVRA 492.6K
- DSU 148.2K
- Earning Date
- ZVRA 11-12-2024
- DSU 01-01-0001
- Dividend Yield
- ZVRA N/A
- DSU 10.06%
- EPS Growth
- ZVRA N/A
- DSU N/A
- EPS
- ZVRA N/A
- DSU N/A
- Revenue
- ZVRA $24,489,000.00
- DSU N/A
- Revenue This Year
- ZVRA N/A
- DSU N/A
- Revenue Next Year
- ZVRA $384.62
- DSU N/A
- P/E Ratio
- ZVRA N/A
- DSU N/A
- Revenue Growth
- ZVRA 47.85
- DSU N/A
- 52 Week Low
- ZVRA $4.20
- DSU $9.22
- 52 Week High
- ZVRA $9.76
- DSU $11.40
- Technical
- Relative Strength Index (RSI)
- ZVRA 45.71
- DSU 43.62
- Support Level
- ZVRA $7.61
- DSU $10.71
- Resistance Level
- ZVRA $8.10
- DSU $10.80
- Average True Range (ATR)
- ZVRA 0.37
- DSU 0.09
- MACD
- ZVRA -0.02
- DSU -0.01
- Stochastic Oscillator
- ZVRA 40.30
- DSU 21.74
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About DSU Blackrock Debt Strategies Fund Inc.
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.